Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...

November 6, 2024Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $1.37, expectations were $0.14.

Emergent BioSolutions Inc (EBS) reports a robust financial performance with a 9% revenue increase and significant debt reduction, despite challenges in Narcan sales.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

On Thursday, Emergent Biosolutions Inc (EBS) stock saw a modest uptick, ending the day at $11 which represents a slight increase of $1.80 or 19.57% from the prior close of $9.2. The stock opened at ...

A Democratic-controlled House — even by a one- or two-seat margin — would trip up efforts to renew prized tax breaks set to expire in 2025.

Amazon is reportedly discussing an additional multi-billion dollar investment in artificial intelligence startup Anthropic, ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...